STAT

China embraces a revolution in genetic testing, seeking answers on destiny and identity

Tech-savvy and college-educated young professionals are driving demand for genetic testing in #China, as they seek answers to guide their lifestyle choices.

BEIJING — It was from the news of American actress Angelina Jolie’s double mastectomy that Yang Yang learned it would be possible to have her DNA sequenced. A white-collar worker from Chongqing, a major city in southwest China, Yang admired her idol’s decision in 2013 to take her future into her own hands after a genetic test revealed a high risk of breast cancer.

Five years later, Yang has discovered that genetic testing services are not only available to Hollywood stars, but also to the average Chinese citizen. For RMB 299 ($43), she ordered a “Genetic Discovery Kit” from 23Mofang, the largest direct-to-consumer genetics testing company in China, spat into a test tube, and then returned it for analysis.

Two weeks later, Yang’s test results, displayed on a slick mobile phone app, informed her that she was

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT1 min read
STAT+: In Large Trial, Guardant Health’s Blood Test Detects Colon Cancer, But Less Reliably At Earliest Or Precancerous Stages
If approved, Guardant Health’s liquid biopsy is likely to be a strong new addition to colorectal cancer screening tools, particularly for patients who currently choose not to get screened.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks